106 related articles for article (PubMed ID: 3748469)
1. High-affinity agonist binding to rat brainstem muscarinic receptors is eliminated by low pH.
Anthony BL; Aronstam RS
Neurosci Lett; 1986 Aug; 69(1):84-8. PubMed ID: 3748469
[TBL] [Abstract][Full Text] [Related]
2. Effects of halothane on high affinity agonist binding and guanine nucleotide sensitivity of muscarinic acetylcholine receptors from brainstem of rat.
Dennison RL; Anthony BL; Narayanan TK; Aronstam RS
Neuropharmacology; 1987 Aug; 26(8):1201-5. PubMed ID: 3116449
[TBL] [Abstract][Full Text] [Related]
3. Effect of pH on muscarinic acetylcholine receptors from rat brainstem.
Anthony BL; Aronstam RS
J Neurochem; 1986 Feb; 46(2):556-61. PubMed ID: 3079819
[TBL] [Abstract][Full Text] [Related]
4. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
Baker SP; Posner P
Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
[TBL] [Abstract][Full Text] [Related]
5. Temperature effect on the detection of muscarinic receptor-G protein interactions in ligand binding assays.
Aronstam RS; Narayanan TK
Biochem Pharmacol; 1988 Mar; 37(6):1045-9. PubMed ID: 3128292
[TBL] [Abstract][Full Text] [Related]
6. Evidence of paired M2 muscarinic receptors.
Potter LT; Ballesteros LA; Bichajian LH; Ferrendelli CA; Fisher A; Hanchett HE; Zhang R
Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
[TBL] [Abstract][Full Text] [Related]
7. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
Martin MW; Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
[TBL] [Abstract][Full Text] [Related]
8. Prevention of guanine nucleotide-induced reductions in muscarinic agonist binding to rabbit ileal submucosal membranes by lidamidine and tetracaine.
Bleakman D; Naftalin RJ
Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):366-72. PubMed ID: 2900471
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
10. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Ladner CJ; Lee JM
Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
[TBL] [Abstract][Full Text] [Related]
11. M2-muscarinic receptors: how does ligand binding affinity relate to intrinsic activity?
Van Gelderen JG; Daeffler L; Scherrer D; Mousli M; Landry Y; Gies JP
J Recept Signal Transduct Res; 1996; 16(1-2):135-48. PubMed ID: 8771535
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors.
Lockhart B; Closier M; Howard K; Steward C; Lestage P
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):429-38. PubMed ID: 11330337
[TBL] [Abstract][Full Text] [Related]
13. Diethyl ether effects on muscarinic acetylcholine receptor complexes in rat brainstem.
Anthony BL; Dennison RL; Narayanan TK; Aronstam RS
Biochem Pharmacol; 1988 Nov; 37(21):4041-6. PubMed ID: 3142483
[TBL] [Abstract][Full Text] [Related]
14. Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics.
Anthony BL; Dennison RL; Aronstam RS
Neurosci Lett; 1989 Apr; 99(1-2):191-6. PubMed ID: 2501717
[TBL] [Abstract][Full Text] [Related]
15. Effect of pH on binding of agonists and antagonists to rat heart muscarinic receptors.
Asselin J; Waelbroeck M; Robberecht P; de Neef P; Christophe J
Biochem J; 1983 Oct; 216(1):11-9. PubMed ID: 6651771
[TBL] [Abstract][Full Text] [Related]
16. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex.
Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J
Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357
[TBL] [Abstract][Full Text] [Related]
17. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
18. Differences between rat dorsal and ventral hippocampus in muscarinic receptor agonist binding and interaction with phospholipase C.
Garcia Ruiz AJ; Zambelli M; La Porta C; Ladinsky H; Consolo S
Eur J Pharmacol; 1993 Jan; 244(2):125-31. PubMed ID: 8432309
[TBL] [Abstract][Full Text] [Related]
19. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
Harden TK; Meeker RB; Martin MW
J Pharmacol Exp Ther; 1983 Dec; 227(3):570-7. PubMed ID: 6317839
[TBL] [Abstract][Full Text] [Related]
20. An [3H]oxotremorine binding method reveals regulatory changes by guanine nucleotides in cholinergic muscarinic receptors of cerebral cortex.
Raskovsky S; Aguilar JS; Jerusalinsky D; De Robertis E
Neurochem Res; 1988 Jun; 13(6):525-30. PubMed ID: 3405377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
